(Received July 10, 1986) In previous studies,1-3) we demonstrated that N-allyl substituted derivatives of pentobarbital (PB), barbital (B) and barbituric acid exhibited different pharmacological activities in mice. N-Monoallylbarbital displayed more potent hypnotic activity than B .2) Further, these allyl derivatives possessed a potent synergistic effect on sedative hypnotic-induced responses . In contrast, N,N'-diallylpentobarbital apparently showed a shortening effect on the Binduced sleeping time.1) These results indicate the complexity of action of allyl-substituted barbiturates. In connection with the above findings, the present study was designed to investigate systematically the pharmacological activities of allyl-substituted phenobarbital (PheB), amobarbital (AB) and thiopental (TP), although syntheses and/or studies of the hypnotic activity of N-allyl derivatives of PheB and AB have already been reported. 4 -7) In order to evaluate the antagonistic or potentiating properties of these allyl compounds and to compare the results with those obtained previously,1 -3) we further examined the pharmacological activities of allyl derivatives of PheB, AB and TP. For this purpose, three kinds of barbiturates having an ethyl group and a phenyl, 3-methylbutyl or 1-methylbutyl group at the 5-position, and having = O or = S at the 2-position of the barbiturate ring were chosen.
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1) Pharmacological Activity
Analytical data for N-(or S-) allyl barbiturates synthesized for the studies are listed on Table I. Table II summarizes the pharmacological activities of N-(or S-) allyl-substituted drivatives. N-Monoallyl-substituted derivatives of PheB, AB and TP (MAPheB, MAAB and MATP) possessed some hypnotic and anticonvulsant activities. However, the activities of these N-monoallyl compounds were less potent than those of the parent compounds. MATP had the most potent anticonvulsant activity among these allyl compounds. N,S-Diallylthiopental (N,S-DATP) possessed some hypnotic activity, although the compound did not show any anticonvulsant activity even at 250 mg/kg, i.p. On the other hand, N,N'-diallylsubstituted derivatives of PheB, AB and TP (DAPheB, DAAB and DATP) exhibited neither hypnotic nor anticonvulsant activity. The acute toxicities of these allyl compounds were lower than those of the corresponding parent compounds. induced sleep were obtained at 15 30 min, as reported previously.1-2) As shown in Table III , MAPheB (80 mg/kg, i.p.) markedly prolonged the barbiturate-induced sleeping time in all cases. DAPheB (80 mg/kg, i.p.) also significantly prolonged the B-(p <0.05), AB-(p <0.01) and PB-(p <0.01) induced sleeping times, but not that of PheB or TP. Potentiation of the PBinduced sleep by DAPheB was about the same as that of MAPheB, although the effect of DAPheB on the AB-induced sleeping time was only about half of that by MAPheB. both compounds of the PheB-induced sleep was dose-dependent. When 150 or 180 mg/kg, i.p. of PheB was given, MAPheB exhibited a more potent prolonging effect than DAPheB.
2.2) MAAB and DAAB
The peak effects of MAAB and DAAB on the AB-induced sleep were at 30 and 15 min, respectively. As shown in Table IV , MAAB significantly (p <0.01) prolonged the barbiturate-induced sleeping times, except in the case of B. In particular, MAAB potentiated the PheB-induced sleep 25-fold over the control level. DAAB also exhibited a prolonging effect on the barbiturate-induced sleep, except in the case of TP. DAAB. was more potent than MAAB in potentiating B-and AB-induced sleeping times. Figure 2 shows the dose-response relationship (5, 20 and 40 mg/kg, i.p.) for the effects of MAAB and DAAB on the AB (60, 80 and 100 mg/kg, i.p.)-induced sleep. Potentiation of the AB-induced sleep by MAAB was evident at doses lower than HD50 of MAAB. The slope of the plot for the DAAB-treated group is steeper than that in the case of the MAAB-treated group. Potentiation of the AB-induced sleeping time by DAAB was stronger than that by MAAB. Table V shows the interactions of MATP, DATP and N,S-DATP with PB. MATP and DATP significantly (p <0.01 and p<0.05, respectively) prolonged the PB-induced sleeping time 12-fold and 13-fold, respectively, as compared with the control. The novel compound, N,S-DATP, also markedly prolonged the PB-induced sleeping time 20-fold. Potentiation of the PB-induced sleep by DATP was as effective as that by MATP.
2.3) MATP, DATP and N,S-DATP

Discussion
MAPheB, MAAB, MATP, and N,S-DATP exhibited some hypnotic activity, although these derivatives were less active than the parent barbiturates.
MAPheB, MAAB and MATP also showed some anticonvulsant activity. It has been reported that monomethoxymethyl derivatives of PheB possess potent anticonvulsant activity') and N-monoallyl-B has potent hypnotic activity.2) However, the present study indicated that introduction of an allyl group into the barbiturate ring resulted in a decrease of the depressant effect of the parent compound. The results were the same as in the case of PB reported previously." DAPheB, DAAB and DATP did not show hypnotic and anticonvulsant activities. The acute toxicities (LD50's) of allyl compounds were lower than those of the corresponding parent compound. MAPheB, which has some hypnotic activity, prolonged the sleeping times induced by all barbiturates. Among all allyl derivatives of barbiturates tested, MAAB had the most potent It has been reported that N-methyl-TP has a very high lipid/water partition coefficient9) and that the concentration of N-methyl-TP in fat was 40 times the plasma concentration at 6 h after administration in dogs.10) TP can bind to serum albumin more strongly than comparable barbiturates and will partially displace the latter from serum albumin .11) Allyl derivatives of TP, which have higher lipid solubility , may affect the binding of PB to serum albumin, so that the concentration of free PB in plasma increases, leading to a higher concentration of PB in the brain.
In conclusion, the results of the present study indicate that allyl derivatives of PheB , AB and TP have different plarmacological activities and that diallyl derivatives of these barbiturates, as well as the N-monoallylbarbiturates, potentiate the barbiturate-induced sleep via their central depressant effect. 
